ii-key-sars-cov-2 coronavirus peptide vaccine
Generic: coronavirus peptide vaccine
ii-key-sars-cov-2 coronavirus peptide vaccine: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| GENEREX BIOTECHNOLOGY CORP (GNBT) | Preclinical |
Get deeper analysis on ii-key-sars-cov-2 coronavirus peptide vaccine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis